Causal Mediation Analyses for the Natural Course of Hepatitis C: A Prospective Cohort Study
2024

Understanding How Hepatitis C Affects Mortality

Sample size: 18972 publication Evidence: high

Author Information

Author(s): Yi-Ting Huang, Yao-Chun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Chien-Jen Chen, Yen-Tsung Huang

Primary Institution: Academia Sinica

Hypothesis

What is the role of intrahepatic and extrahepatic diseases in mediating HCV-induced mortality?

Conclusion

Both intrahepatic and extrahepatic manifestations mediated approximately half of HCV-induced mortality.

Supporting Evidence

  • 54.1% of HCV-induced mortality was mediated by intrahepatic diseases.
  • 45.9% of mortality was mediated by extrahepatic diseases.
  • Septicemia was a major extrahepatic mediator with a 25.2% contribution to HCV-induced mortality.

Takeaway

Hepatitis C can make people sick in different ways, and both liver problems and other diseases can lead to death from it.

Methodology

A community-based cohort study with over 25 years of follow-up was conducted, linking cohort data to Taiwan’s National Health Insurance Research Database.

Potential Biases

Potential misclassification of disease status may lead to an underestimation of mediation effects.

Limitations

The study only included diseases with a prevalence between 10% and 90%, which may exclude rare diseases.

Participant Demographics

The cohort included 18,972 participants, with 934 being HCV carriers, generally older, more women, and with higher ALT levels.

Statistical Information

Confidence Interval

95% CI, 1.22–1.41

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.2188/jea.JE20240034

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication